APCCC 2022 | PSMA-PET scanning and management of cN1 prostate cancer

Darren Poon, MBChB, FRCR, FHKCR, FHKAM, The Chinese University of Hong Kong, Hong Kong discusses the novel prostate specific antigen (PSMA) PET scan technique for prostate cancer. Dr. Poon describes how data gathered in future studies will provide insight into the applications of novel imaging techniques to the management of locally advanced prostate cancer, particularly clinically node-positive (cN1) prostate cancer. This interview took place at the APCCC 2022 conference, held in Lugano, Switzerland.